Making sense of GLP-1 trends and PBM dynamics

GLP-1 agonists are emerging as a key development in chronic condition management, but they come with questions about clinical value, cost management, and evolving guidelines. Employers face the challenge of balancing these new therapies with practical benefits strategies. Meanwhile, pharmacy benefit managers (PBMs) may not always approach these trends as expected.

Join our panel of specialists—Rick Kelly, FSA, Division Leader and National Pharmacy Practice Leader; Karen Springstead, Vice President, National Pharmacy Practice; Zak Kornblum, Pharm.D., Pharmacy Clinical Director; hosted by Kate Moher, President, National Employee Health & Benefits—as they explore:

• Key trends in GLP-1 usage and clinical reviews
• The impact of changing clinical guidelines
• Evaluating the clinical value of GLP-1 therapies
• The evolving role of PBMs and management strategies for GLP-1s

What you'll learn:

• Insights into the latest trends and their impact on benefit planning
• Strategies for understanding PBM practices and effective management
• Forward-looking perspectives on pharmacy industry developments and next steps

This webinar is designed for HR professionals, benefits managers, and anyone seeking to stay informed and proactive about pharmacy benefits.

Register now to gain expert insights and practical strategies for navigating the evolving GLP-1 landscape.

Click here to connect with one of our local consultants to learn more about this topic.